Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

3Total
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Unknown4
Terminated1
Recruiting1

Clinical Trials (6)

Showing 6 of 6 trials
NCT03913117Phase 1Recruiting

Study of Treatment for HPV16+ ASC-US or LSIL

NCT03911076Phase 2Terminated

Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL

NCT06208319Unknown

Development and Evaluation of an Artificial Intelligence Tool for Colposcopy Assistance

NCT05808816Phase 4Unknown

"Lactobacillus Crispatus M247, LSIL and Microbiota"

NCT03409471Unknown

HPV Test of Urine and Self Collected Vaginal Samples for Cervical Cancer Screening Study

NCT01416922Unknown

oncoFISH Cervical Test for Detection of 3q26 Region Gain

Showing all 6 trials

Research Network

Activity Timeline